Kidney Neoplasms
"Kidney Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the KIDNEY.
| Descriptor ID |
D007680
|
| MeSH Number(s) |
C04.588.945.947.535 C12.758.820.750 C12.777.419.473 C13.351.937.820.535 C13.351.968.419.473
|
| Concept/Terms |
Kidney Neoplasms- Kidney Neoplasms
- Kidney Neoplasm
- Neoplasm, Kidney
- Renal Neoplasms
- Neoplasm, Renal
- Neoplasms, Renal
- Renal Neoplasm
- Neoplasms, Kidney
Cancer of Kidney- Cancer of Kidney
- Kidney Cancers
- Renal Cancer
- Cancer, Renal
- Cancers, Renal
- Renal Cancers
- Cancer of the Kidney
- Kidney Cancer
- Cancer, Kidney
- Cancers, Kidney
|
Below are MeSH descriptors whose meaning is more general than "Kidney Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Kidney Neoplasms".
This graph shows the total number of publications written about "Kidney Neoplasms" by people in this website by year, and whether "Kidney Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 2 | 0 | 2 | | 1999 | 2 | 0 | 2 | | 2000 | 3 | 0 | 3 | | 2001 | 3 | 0 | 3 | | 2003 | 1 | 0 | 1 | | 2004 | 4 | 0 | 4 | | 2005 | 1 | 0 | 1 | | 2006 | 2 | 0 | 2 | | 2007 | 6 | 0 | 6 | | 2008 | 5 | 2 | 7 | | 2009 | 5 | 3 | 8 | | 2010 | 6 | 2 | 8 | | 2011 | 8 | 1 | 9 | | 2012 | 11 | 0 | 11 | | 2013 | 11 | 3 | 14 | | 2014 | 15 | 1 | 16 | | 2015 | 10 | 0 | 10 | | 2016 | 8 | 0 | 8 | | 2017 | 14 | 2 | 16 | | 2018 | 16 | 1 | 17 | | 2019 | 25 | 0 | 25 | | 2020 | 19 | 0 | 19 | | 2021 | 24 | 1 | 25 | | 2022 | 20 | 0 | 20 | | 2023 | 16 | 0 | 16 | | 2024 | 22 | 1 | 23 | | 2025 | 27 | 0 | 27 | | 2026 | 11 | 1 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Kidney Neoplasms" by people in Profiles.
-
Urun Y, Sridharan K, Zgura A, Zayed A, Laguado MIZ, Yetisyigit T, Yano A, Wenzel M, Vau N, Tural D, Trindade K, Tran B, Ting FIL, Templeton AJ, Takeshita H, Sunela K, Souza VC, Sooro MA, Soares A, Siva S, Singh A, Silveira G, Shah S, Seront E, Schutz FA, Schurmann MLV, Schieber T, Scagliarini S, Sargsyan A, Simonetti CS, Rushanyan M, Roviello G, Rodriguez-Vida A, Rodriguez Gonzalez OE, Roberts R, Van der Veldt AAM, Rizzo M, Rizzo A, Poprach A, Pirshtuk A, Pinto A, Pierce E, Peñaloza JM, Pedrani M, Park SH, Okunade IA, Odounga KF, Noriega J, Noorzai E, Coronel MTN, Navratil J, Myint ZW, Mutavdzic V, Mukuku O, Mugarura R, Marques Monteiro FS, Mohamed AH, Mmereki D, Messina C, Melichar B, Mukaz Mbey P, Maturana E, Matthews D, Massari F, Martínez E, Maitre P, Maison P, Ndjembidouma BCM, Lu K, Li J, Li H, de Moura Leite L, Lalani AA, Küronya Z, Kucharz J, Koumba AB, Kopp RM, Kopecky J, Kihn-Alarcón AJ, Keskin Ö, Kabdullina K, Juarez Á, Fita MJJ, Jardim DL, James LG, Grande E, De Liaño AG, Giannatempo P, Ghosn M, Gauna C, Quiroga MNG, Fujita K, Pereira Freitas MR, Fiala O, Lazzaro MF, Pacheco GMF, Esan TO, Esan DT, Du Plessis D, Delgado SN, Crabb SJ, Cano RC, Corrales L, Chen J, Cayol F, Silva CC, Carneiro APCD, Caprinciu GA, Campos S, Büttner T, Buti S, Bukhari N, Buchler T, Bourlon MT, Bolek H, Boegemann M, Bilen MA, Vaca LB, Bastos DA, Barthelemy P, Bardakhchyan S, Barbu MA, Baranseh J, Bamias A, Bakenga A, Anguera G, Angel M, Silva CAC, Alonso-Gordoa T, Almugbel F, Almufti R, Almeida TL, Aliyev A, Aliaga C, Aleem U, Akkus E, Aceituno LG, Abidi SH, Abahssain H, Tartari F, Molina-Cerrillo J, Santoni M. Global disparities in the availability and reimbursement of systemic therapies for renal cell carcinoma: results of the International ARON-AID Survey. Oncologist. 2026 Oct 07; 31(11).
-
Evageliou NF, Renfro LA, Vallance KL, Varela CR, Benedetti DJ, Cost NG, Ehrlich PF, Kalapurakal JA, Khanna G, Aldrink JH, Glick RD, Ortiz MV, Parsons LN, Paulino AC, Artunduaga M, Smith EA, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA. Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies. Cancer. 2026 Oct 01; 132(19):e70610.
-
Tasaki Y, Sato K, Hamamoto S, Sugiyama Y, Ikoma H, Kawase K, Suzuki H, Noda Y, Usami M, Tsubouchi Y, Kato R, Sakata T, Tomita M, Mimura Y, Nagai T, Unno R, Etani T, Naiki T, Yasui T, Furukawa-Hibi Y. Impact of Organ-Specific Severe Immune-Related Adverse Events on Long-Term Survival and Treatment Transitions in Metastatic Renal Cell Carcinoma: A 5-Year Multicenter Multistate Analysis. Cancer Med. 2026 Oct; 15(10):e72410.
-
Tomita M, Tasaki Y, Hamamoto S, Osawa T, Yamashita S, Matsumoto R, Ikoma H, Kawase K, Mimura Y, Sugiyama Y, Yasui T, Furukawa-Hibi Y. Eosinophil Dynamics May Help Differentiate Immune-Related From TKI-Related Adverse Events During IO-TKI Therapy for Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study. Cancer Med. 2026 Oct; 15(10).
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Treece AL, Gratias EJ, Cost NG, Grundy PE, Fernandez CV, Dome JS, Geller JI. Feasibility of Real-Time Central Risk Assignment for Children's Oncology Group Pediatric Renal Tumor Trials. Pediatr Blood Cancer. 2026 Nov; 73(11):e70639.
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS. Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatr Blood Cancer. 2026 Oct; 73(10):e70515.
-
Murphy AJ, Santiago T, Cost NG. Wilms Tumor. Surg Oncol Clin N Am. 2026 10; 35(4):695-714.
-
Furtado Neves PJ, Simioni A, Ishida AH, Kim SP, Gleisner AL, Mungo B, McCarter MD, Jacobs DL, Malgor EA, Malgor RD. Trends and Outcomes of Surgical Reconstruction of the IVC after Oncologic Resection. J Am Coll Surg. 2026 Jun 01; 242(6):1568-1578.
-
Rinehardt HN, Tracy ET, Paredes A, Beckhorn C, Leraas HJ, Fusco J, McKay KG, Kontchou NT, Kastenberg ZJ, Hoyt DW, Roach J, Myers EK, Cost NG, Mullapudi B, Marchese CR, Jensen AR, Lautz TB, Carter M, Dasgupta R, Lundstedt J, Brungardt JG, Talbot L, Davidoff AM, Murphy AJ, Aldrink JH, Mansfield S, Piche N, Le-Nguyen A, Lal DR, Craig BT, Schuh JM, Cromeens BP, Mannava S, Castle S, Lopez A, Mello K, Short J, Petroze RT, Rajavel S, Thompson GR, Mattei P, Rothstein DH, Fialkowski E, Fowler K, Martchenke N, Rich BS, Glick RD, Brown EG, Doyle K, Abril P, Seemann N, Davidson J, Wilson CA, Le HD, Joshi D, Stellon M, Ahmed T, Dimmer A, Ehrlich PF, Hammoud M, Williams K, Grant CN, Gorgy M, Polites SF, Debertin J, Cameron DB, Stetson A, Kim ES, Lee WG, Barkhordar A, Austin M, Coakley BA, Kahan A, Murphy JT, Pitonak M, Boehmer C, Malek MM. Outcomes and Surgical Management of Malignant Rhabdoid Tumor of the Kidney: A Report From the Pediatric Surgical Oncology Research Collaborative. Pediatr Blood Cancer. 2026 Jun; 73(6):e70296.
-
Gupta N, Toumazos K, Walker J, Cranford W, Feygin Y, Zack J, Strup SE, Hensley A, Kieran K, Cost NG, Sorge C, Hensley P, McLouth C, Buchanan AF. Survivorship After Kidney Cancer in Children, Adolescents, and Young Adults-What Is Causing Death and When? Urology. 2026 May; 211:77-83.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|